Abstract
We demonstrate here that coexpression of ROMK2, an inwardly rectifying ATP-sensitive renal K+ channel (IKATP) with cystic fibrosis transmembrane regulator (CFTR) significantly enhances the sensitivity of ROMK2 to the sulfonylurea compound glibenclamide. When expressed alone, ROMK2 is relatively insensitive to glibenclamide. The interaction between ROMK2, CFTR, and glibenclamide is modulated by altering the phosphorylation state of either ROMK2, CFTR, or an associated protein, as exogenous MgATP and the catalytic subunit of protein kinase A significantly attenuate the inhibitory effect of glibenclamide on ROMK2. Thus CFTR, which has been demonstrated to interact with both Na+ and Cl- channels in airway epithelium, modulates the function of renal ROMK2 K+ channels.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adenosine Triphosphate / pharmacology*
-
Animals
-
Chloride Channels / physiology
-
Cyclic AMP-Dependent Protein Kinases / pharmacology
-
Cystic Fibrosis Transmembrane Conductance Regulator / biosynthesis
-
Cystic Fibrosis Transmembrane Conductance Regulator / physiology*
-
Female
-
Glyburide / pharmacology*
-
Kidney / physiology*
-
Membrane Potentials / drug effects
-
Membrane Potentials / physiology
-
Oocytes / drug effects
-
Oocytes / physiology
-
Patch-Clamp Techniques
-
Phosphorylation
-
Potassium Channels / biosynthesis
-
Potassium Channels / drug effects
-
Potassium Channels / physiology*
-
Potassium Channels, Inwardly Rectifying*
-
Sodium Channels / physiology
-
Xenopus laevis
Substances
-
Chloride Channels
-
Potassium Channels
-
Potassium Channels, Inwardly Rectifying
-
Sodium Channels
-
Cystic Fibrosis Transmembrane Conductance Regulator
-
Adenosine Triphosphate
-
Cyclic AMP-Dependent Protein Kinases
-
Glyburide